TCF1-LEF1 co-expression identifies a multipotent progenitor cell (T


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
08 Apr 2024
Historique:
received: 21 01 2024
accepted: 06 03 2024
medline: 9 4 2024
pubmed: 9 4 2024
entrez: 8 4 2024
Statut: aheadofprint

Résumé

Repetitive exposure to antigen in chronic infection and cancer drives T cell exhaustion, limiting adaptive immunity. In contrast, aberrant, sustained T cell responses can persist over decades in human allergic disease. To understand these divergent outcomes, we employed bioinformatic, immunophenotyping and functional approaches with human diseased tissues, identifying an abundant population of type 2 helper T (T

Identifiants

pubmed: 38589618
doi: 10.1038/s41590-024-01803-2
pii: 10.1038/s41590-024-01803-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : T32AI007306
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : K23AI139352
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : U19AI095219

Informations de copyright

© 2024. Springer Nature America, Inc.

Références

Paley, M. A. et al. Progenitor and terminal subsets of CD8
pubmed: 23197535 pmcid: 3653769 doi: 10.1126/science.1229620
Im, S. J. et al. Defining CD8
pubmed: 27501248 pmcid: 5297183 doi: 10.1038/nature19330
Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8
pubmed: 27533016 doi: 10.1016/j.immuni.2016.07.021
Wu, T. et al. The TCF1–Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness. Sci. Immunol. 1, eaai8593 (2016).
pubmed: 28018990 pmcid: 5179228 doi: 10.1126/sciimmunol.aai8593
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998–1013 (2018).
pubmed: 30388456 pmcid: 6641984 doi: 10.1016/j.cell.2018.10.038
Philip, M. & Schietinger, A. CD8
pubmed: 34253904 doi: 10.1038/s41577-021-00574-3
Walker, J. A. & McKenzie, A. N. J. T
pubmed: 29082915 doi: 10.1038/nri.2017.118
Nakayama, T. et al. T
pubmed: 27912316 doi: 10.1146/annurev-immunol-051116-052350
Gause, W. C., Rothlin, C. & Loke, P. Heterogeneity in the initiation, development and function of type 2 immunity. Nat. Rev. Immunol. 20, 603–614 (2020).
pubmed: 32367051 pmcid: 9773851 doi: 10.1038/s41577-020-0301-x
Nelson, R. W. et al. T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity. Immunity 42, 95–107 (2015).
pubmed: 25601203 pmcid: 4355167 doi: 10.1016/j.immuni.2014.12.022
Bangert, C. et al. Persistence of mature dendritic cells, T
pubmed: 33483337 doi: 10.1126/sciimmunol.abe2749
Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714–730 (2019).
pubmed: 31348891 pmcid: 6662628 doi: 10.1016/j.cell.2019.06.029
Ma, J. et al. Single-cell analysis pinpoints distinct populations of cytotoxic CD4
pubmed: 34389612 doi: 10.1126/sciimmunol.abg6356
Liu, X. et al. Single-cell RNA sequencing of subcutaneous adipose tissues identifies therapeutic targets for cancer-associated lymphedema. Cell Discov. 8, 58 (2022).
pubmed: 35725971 pmcid: 9209506 doi: 10.1038/s41421-022-00402-5
Wen, T. et al. Single-cell RNA sequencing identifies inflammatory tissue T cells in eosinophilic esophagitis. J. Clin. Invest. 129, 2014–2028 (2019).
pubmed: 30958799 pmcid: 6486341 doi: 10.1172/JCI125917
Morgan, D. M. et al. Clonally expanded, GPR15-expressing pathogenic effector T
pubmed: 34389613 pmcid: 8686696 doi: 10.1126/sciimmunol.abi5586
Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289–1296 (2019).
pubmed: 31740819 pmcid: 6884693 doi: 10.1038/s41592-019-0619-0
Alladina, J. et al. A human model of asthma exacerbation reveals transcriptional programs and cell circuits specific to allergic asthma. Sci. Immunol. 8, eabq6352 (2023).
pubmed: 37146132 pmcid: 10440046 doi: 10.1126/sciimmunol.abq6352
Siddiqui, S. et al. Epithelial miR-141 regulates IL-13-induced airway mucus production. JCI Insight 6, e139019 (2021).
pubmed: 33682796 pmcid: 8021117 doi: 10.1172/jci.insight.139019
Okano, M. et al. Interleukin-33-activated neuropeptide CGRP-producing memory T
pubmed: 36272417 doi: 10.1016/j.immuni.2022.09.016
Liu, Y. et al. Classification of human chronic inflammatory skin disease based on single-cell immune profiling. Sci. Immunol. 7, eabl9165 (2022).
pubmed: 35427179 pmcid: 9301819 doi: 10.1126/sciimmunol.abl9165
Mitson-Salazar, A. et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T
pubmed: 26431580 doi: 10.1016/j.jaci.2015.08.007
Wambre, E. et al. A phenotypically and functionally distinct human T
pubmed: 28768806 pmcid: 5987220 doi: 10.1126/scitranslmed.aam9171
Faustino, L. D. et al. Interleukin-33 activates regulatory T cells to suppress innate γδ T cell responses in the lung. Nat. Immunol. 21, 1371–1383 (2020).
pubmed: 32989331 pmcid: 7578082 doi: 10.1038/s41590-020-0785-3
Morimoto, Y. et al. Amphiregulin-producing pathogenic memory T helper 2 cells instruct eosinophils to secrete osteopontin and facilitate airway fibrosis. Immunity 49, 134–150 (2018). .
Zhao, X., Shan, Q. & Xue, H.-H. TCF1 in T cell immunity: a broadened frontier. Nat. Rev. Immunol. 22, 147–157 (2022).
pubmed: 34127847 doi: 10.1038/s41577-021-00563-6
Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921–2934 (2017).
pubmed: 28930685 pmcid: 5646692 doi: 10.1016/j.celrep.2017.08.078
Skon, C. N. et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8
pubmed: 24162775 pmcid: 3844557 doi: 10.1038/ni.2745
Hombrink, P. et al. Programs for the persistence, vigilance and control of human CD8
pubmed: 27776108 doi: 10.1038/ni.3589
Schnell, A. et al. Stem-like intestinal T
pubmed: 34875227 pmcid: 8900676 doi: 10.1016/j.cell.2021.11.018
Karmaus, P. W. F. et al. Metabolic heterogeneity underlies reciprocal fates of T
pubmed: 30568299 doi: 10.1038/s41586-018-0806-7
Gearty, S. V. et al. An autoimmune stem-like CD8 T cell population drives type 1 diabetes. Nature 602, 156–161 (2022).
pubmed: 34847567 doi: 10.1038/s41586-021-04248-x
Wang, W. et al. Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis. Nat. Immunol. 23, 1484–1494 (2022).
pubmed: 36138182 doi: 10.1038/s41590-022-01312-0
Utzschneider, D. T. et al. Active maintenance of T cell memory in acute and chronic viral infection depends on continuous expression of FOXO1. Cell Rep. 22, 3454–3467 (2018).
pubmed: 29590615 pmcid: 5942184 doi: 10.1016/j.celrep.2018.03.020
Delpoux, A. et al. Continuous activity of Foxo1 is required to prevent anergy and maintain the memory state of CD8
pubmed: 29282254 pmcid: 5789410 doi: 10.1084/jem.20170697
Staron, M. M. et al. The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8
pubmed: 25464856 pmcid: 4270830 doi: 10.1016/j.immuni.2014.10.013
Tibbitt, C. A. et al. Single-cell RNA sequencing of the T helper cell response to house dust mites defines a distinct gene expression signature in airway T
doi: 10.1016/j.immuni.2019.05.014
Ulrich, B. J. et al. Allergic airway recall responses require IL-9 from resident memory CD4
pubmed: 35302861 pmcid: 9295820 doi: 10.1126/sciimmunol.abg9296
Brown, I. K. et al. Single cell analysis of host response to helminth infection reveals the clonal breadth, heterogeneity, and tissue-specific programming of the responding CD4
pubmed: 34106992 pmcid: 8216541 doi: 10.1371/journal.ppat.1009602
Radtke, D. et al. T
pubmed: 35950748 pmcid: 9391044 doi: 10.7554/eLife.74183
Hara-Chikuma, M. et al. Chemokine-dependent T cell migration requires aquaporin-3–mediated hydrogen peroxide uptake. J. Exp. Med. 209, 1743–1752 (2012).
pubmed: 22927550 pmcid: 3457725 doi: 10.1084/jem.20112398
Kurtulus, S. et al. TIGIT predominantly regulates the immune response via regulatory T cells. J. Clin. Invest. 125, 4053–4062 (2015).
pubmed: 26413872 pmcid: 4639980 doi: 10.1172/JCI81187
Mata, S. H.-D. L. et al. Cytotoxic CD4
doi: 10.1016/j.medj.2023.09.003
Wang, Y.-H. et al. Maintenance and polarization of human T
pubmed: 16782037 doi: 10.1016/j.immuni.2006.03.019
Chen, J. et al. NR4A transcription factors limit CAR T cell function in solid tumours. Nature 567, 530–534 (2019).
pubmed: 30814732 pmcid: 6546093 doi: 10.1038/s41586-019-0985-x
Liu, X. et al. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction. Nature 567, 525–529 (2019).
pubmed: 30814730 pmcid: 6507425 doi: 10.1038/s41586-019-0979-8
Lohoff, M. et al. Early growth response protein-1 (Egr-1) Is preferentially expressed in T helper type 2 (T
pubmed: 19915002 doi: 10.1074/jbc.M109.011585
Wagle, M. V. et al. Antigen-driven EGR2 expression is required for exhausted CD8
pubmed: 33986293 pmcid: 8119420 doi: 10.1038/s41467-021-23044-9
Martinez, G. J. et al. The transcription factor NFAT promotes exhaustion of activated CD8
pubmed: 25680272 pmcid: 4346317 doi: 10.1016/j.immuni.2015.01.006
Geltink, R. I. K., Kyle, R. L. & Pearce, E. L. Unraveling the complex interplay between T cell metabolism and function. Annu. Rev. Immunol. 36, 461–488 (2018).
pubmed: 29677474 doi: 10.1146/annurev-immunol-042617-053019
Chapman, N. M. & Chi, H. Metabolic adaptation of lymphocytes in immunity and disease. Immunity 55, 14–30 (2022).
pubmed: 35021054 pmcid: 8842882 doi: 10.1016/j.immuni.2021.12.012
Chen, Y.-H. et al. Asymmetric PI3K activity in lymphocytes organized by a PI3K-mediated polarity pathway. Cell Rep. 22, 860–868 (2018).
pubmed: 29420173 pmcid: 5806629 doi: 10.1016/j.celrep.2017.12.087
Cosset, É. et al. Glut3 addiction is a druggable vulnerability for a molecularly defined subpopulation of glioblastoma. Cancer Cell 32, 856–868 (2017).
pubmed: 29198914 pmcid: 5730343 doi: 10.1016/j.ccell.2017.10.016
Peng, M. et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science 354, 481–484 (2016).
pubmed: 27708054 pmcid: 5539971 doi: 10.1126/science.aaf6284
Chang, C.-H. et al. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153, 1239–1251 (2013).
pubmed: 23746840 pmcid: 3804311 doi: 10.1016/j.cell.2013.05.016
Wang, Y. et al. The kinase complex mTORC2 promotes the longevity of virus-specific memory CD4
pubmed: 34949833 doi: 10.1038/s41590-021-01090-1
Voss, K. et al. Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus. Sci. Immunol. 8, eabq0178 (2023).
pubmed: 36638190 pmcid: 9936798 doi: 10.1126/sciimmunol.abq0178
Argüello, R. J. et al. SCENITH: a flow cytometry-based method to functionally profile energy metabolism with single-cell resolution. Cell Metab. 32, 1063–1075 (2020).
pubmed: 33264598 pmcid: 8407169 doi: 10.1016/j.cmet.2020.11.007
Lopes, N. et al. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments. Nat. Immunol. 22, 179–192 (2021).
pubmed: 33462452 pmcid: 7610600 doi: 10.1038/s41590-020-00848-3
Riggan, L. et al. The transcription factor Fli1 restricts the formation of memory precursor NK cells during viral infection. Nat. Immunol. 23, 556–567 (2022).
pubmed: 35288713 pmcid: 8989647 doi: 10.1038/s41590-022-01150-0
Johnson, M. O. et al. Distinct regulation of T
pubmed: 30392958 pmcid: 6361668 doi: 10.1016/j.cell.2018.10.001
Healey, D. C. C. et al. Targeting in vivo metabolic vulnerabilities of T
pubmed: 33558372 doi: 10.4049/jimmunol.2001029
Reynolds, G. et al. Developmental cell programs are co-opted in inflammatory skin disease. Science 371, eaba6500 (2021).
pubmed: 33479125 pmcid: 7611557 doi: 10.1126/science.aba6500
Alkon, N. et al. Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis. J. Allergy Clin. Immunol. 152, 420–435 (2023).
pubmed: 37210042 doi: 10.1016/j.jaci.2023.04.019
Upadhyaya, B., Yin, Y., Hill, B. J., Douek, D. C. & Prussin, C. Hierarchical IL-5 expression defines a subpopulation of highly differentiated human T
pubmed: 21849680 doi: 10.4049/jimmunol.1101283
Bachert, C. et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394, 1638–1650 (2019).
pubmed: 31543428 doi: 10.1016/S0140-6736(19)31881-1
Simpson, E. L. et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N. Engl. J. Med. 375, 2335–2348 (2016).
pubmed: 27690741 doi: 10.1056/NEJMoa1610020
Castro, M. et al. Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N. Engl. J. Med. 378, 2486–2496 (2018).
pubmed: 29782217 doi: 10.1056/NEJMoa1804092
Ebina-Shibuya, R. & Leonard, W. J. Role of thymic stromal lymphopoietin in allergy and beyond. Nat. Rev. Immunol. 23, 24–37 (2023).
pubmed: 35650271 doi: 10.1038/s41577-022-00735-y
Taves, M. D. & Ashwell, J. D. Glucocorticoids in T cell development, differentiation and function. Nat. Rev. Immunol. 21, 233–243 (2021).
pubmed: 33149283 doi: 10.1038/s41577-020-00464-0
Kabata, H. et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat. Commun. 4, 2675 (2013).
pubmed: 24157859 doi: 10.1038/ncomms3675
Gowthaman, U. et al. Identification of a T follicular helper cell subset that drives anaphylactic IgE. Science 365, eaaw6433 (2019).
pubmed: 31371561 pmcid: 6901029 doi: 10.1126/science.aaw6433
Rivas, M. N. & Chatila, T. A. Regulatory T cells in allergic diseases. J. Allergy Clin. Immunol. 138, 639–652 (2016).
pmcid: 5023156 doi: 10.1016/j.jaci.2016.06.003
Worm, M. et al. Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis. JAMA Dermatol. 156, 131–143 (2020).
pubmed: 31876900 doi: 10.1001/jamadermatol.2019.3617
Blank, C. U. et al. Defining ‘T cell exhaustion’. Nat. Rev. Immunol. 19, 665–674 (2019).
pubmed: 31570879 pmcid: 7286441 doi: 10.1038/s41577-019-0221-9
Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: an R-based toolkit for single-cell immune receptor analysis. F1000Res. 9, 47 (2020).
pubmed: 32789006 pmcid: 7400693 doi: 10.12688/f1000research.22139.1
Street, K. et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19, 477 (2018).
pubmed: 29914354 pmcid: 6007078 doi: 10.1186/s12864-018-4772-0
Marsh, S., Salmon, M. & Hoffman, P. scCustomize: custom visualizations & functions for streamlined analyses of single cell sequencing (The Comprehensive R Archive Network, 2024).
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
pubmed: 31178118 pmcid: 6687398 doi: 10.1016/j.cell.2019.05.031
Kratchmarov, R. & Brennan, P. Single cell RNA sequencing and single cell TCR sequencing of type 2 lymphocytes in human nasal polyps. GEO https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255544 (2024).

Auteurs

Radomir Kratchmarov (R)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Sarah Djeddi (S)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Garrett Dunlap (G)

Division of Rheumatology, Inflammation, Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Wenqin He (W)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Xiaojiong Jia (X)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Caitlin M Burk (CM)

Center for Immunology and Inflammatory Diseases and Food Allergy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Tessa Ryan (T)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Alanna McGill (A)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Jessica R Allegretti (JR)

Division of Gastroenterology, Hepatology and Endoscopy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Raghu P Kataru (RP)

Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Babak J Mehrara (BJ)

Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Erin M Taylor (EM)

Division of Plastic and Reconstructive Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard University, Boston, MA, USA.

Shailesh Agarwal (S)

Division of Plastic and Reconstructive Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard University, Boston, MA, USA.

Neil Bhattacharyya (N)

Massachusetts Eye & Ear Institute, Harvard Medical School, Boston, MA, USA.

Regan W Bergmark (RW)

Division of Otolaryngology Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA.

Alice Z Maxfield (AZ)

Division of Otolaryngology Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Stella Lee (S)

Division of Otolaryngology Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Rachel Roditi (R)

Division of Otolaryngology Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Daniel F Dwyer (DF)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Joshua A Boyce (JA)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Kathleen M Buchheit (KM)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Tanya M Laidlaw (TM)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Wayne G Shreffler (WG)

Center for Immunology and Inflammatory Diseases and Food Allergy Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Deepak A Rao (DA)

Division of Rheumatology, Inflammation, Immunity, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Maria Gutierrez-Arcelus (M)

Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Patrick J Brennan (PJ)

Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. pbrennan3@bwh.harvard.edu.

Classifications MeSH